- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
In the future, some Covid-19 vaccines may not be jabs in the arm. They could be a nasal spray or even a patch on the skin. Those are just two examples of the kind of next-generation vaccine technology that federal health officials are hoping to help advance.
The US Department of Health and Human Services announced Friday that it has selected three initial next-generation vaccine candidates to receive funding awards to help kick-start planning for Phase 2b clinical trials, slated to begin as early as this winter. Two of those studies involve intranasal vaccine candidates, and one involves a self-amplifying mRNA vaccine candidate.
HHS announced more than $500 million in awards to help advance the development of potential vaccines and therapeutics, which includes those initial three vaccine candidates.
Will those easily work for other vaccines? Or would it need a separate trial for each type?
From the article:
To me, this says that effectiveness against Covid-19 would be a proof-of-concept for the technology. If it works there, maybe it’ll also work for other diseases.